2930 Stock Overview
An investment holding company, provides aesthetic medical services.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Raily Aesthetic Medicine International Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.20 |
| 52 Week High | HK$0.40 |
| 52 Week Low | HK$0.20 |
| Beta | 0.88 |
| 11 Month Change | -31.03% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -35.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2930 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | -14.9% | -4.4% | -1.0% |
| 1Y | n/a | -24.2% | 20.3% |
Return vs Industry: Insufficient data to determine how 2930 performed against the Hong Kong Healthcare industry.
Return vs Market: Insufficient data to determine how 2930 performed against the Hong Kong Market.
Price Volatility
| 2930 volatility | |
|---|---|
| 2930 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.7% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 18.9% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 2930's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 2930's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 321 | Jianliang Song | www.raily.com |
Raily Aesthetic Medicine International Holdings Limited, an investment holding company, provides aesthetic medical services. The company operates through three segments: Aesthetic Medical Services, Consulting Services, and Aesthetic Medical Equipment Products. Its services include aesthetic surgery services, including aesthetic surgical procedures performed on various parts of the face or body; minimally invasive aesthetic services, primarily comprising aesthetic injection procedures; aesthetic dermatology services, such as various aesthetic energy-based procedures; and aesthetic medical management consulting services.
Raily Aesthetic Medicine International Holdings Limited Fundamentals Summary
| 2930 fundamental statistics | |
|---|---|
| Market cap | HK$77.99m |
| Earnings (TTM) | -HK$35.06m |
| Revenue (TTM) | HK$204.58m |
0.4x
P/S Ratio-2.2x
P/E RatioIs 2930 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2930 income statement (TTM) | |
|---|---|
| Revenue | CN¥189.38m |
| Cost of Revenue | CN¥117.89m |
| Gross Profit | CN¥71.49m |
| Other Expenses | CN¥103.95m |
| Earnings | -CN¥32.46m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.058 |
| Gross Margin | 37.75% |
| Net Profit Margin | -17.14% |
| Debt/Equity Ratio | 5.3% |
How did 2930 perform over the long term?
See historical performance and comparison